Organogenesis Holdings Inc.ORGO

Market cap
$668.52M
P/E ratio
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents-----114102104136
Restricted cash--0001101
Accounts Receivable, after Allowance for Credit Loss, Current--343957828982110
Inventory, Net--13232825252826
Prepaid expenses and other current assets--235551014
Total current assets1294,43971126174227223225286
Property and equipment, net--4047607910211689
Intangible assets, net--26213126211612
Goodwill--26262929292929
Operating Lease, Right-of-Use Asset-----49434037
Deferred tax asset, net----032302839
Other assets--1112265
Total assets311313164221294443449460498
Secured Debt, Current----17355-
Finance Lease, Liability, Current-----0-11
Current portion of operating lease obligations related party-------34
Operating Lease, Liability, Current-----1212104
Accounts payable--19282329323129
Accrued expenses and other current liabilities--25232437263039
Total current liabilities478,360466606882758177
Term loan, net of current portion----43716661-
Finance Lease, Liability, Noncurrent-------21
Operating Lease, Liability, Noncurrent related party-------178
Operating Lease, Liability, Noncurrent-----47412025
Other liabilities--1782111
Total liabilities1115117165148201184181113
Temporary Equity, Carrying Amount, Attributable to Parent295293------122
Common Stock, Value, Issued--0000000
Additional paid-in capital57177227299302311320303
Accumulated deficit-233,860-2,327,773-130-171-153-60-45-41-40
Total stockholders' equity554756146242266279263
Total liabilities, redeemable convertible preferred stock, and stockholders' equity311313164221294443449460498